These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 6312019

  • 21. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL, Mathiasen JR, Raffa RB.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [Abstract] [Full Text] [Related]

  • 22. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M, La Regina A, Petrillo P, Tavani A.
    NIDA Res Monogr; 1986 Apr; 75():520-3. PubMed ID: 2828999
    [Abstract] [Full Text] [Related]

  • 23. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC, Robles L, Mosberg HI.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [Abstract] [Full Text] [Related]

  • 24. Centrally administered bombesin affects gastrointestinal transit and colonic bead expulsion through supraspinal mechanisms.
    Koslo RJ, Burks TF, Porreca F.
    J Pharmacol Exp Ther; 1986 Jul; 238(1):62-7. PubMed ID: 3755171
    [Abstract] [Full Text] [Related]

  • 25. Involvement of mu, delta and kappa receptors in morphine-induced tolerance in the guinea pig myenteric plexus.
    Leedham JA, Bennett LE, Taylor DA, Fleming WW.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):295-301. PubMed ID: 1656024
    [Abstract] [Full Text] [Related]

  • 26. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
    Hammond DL, Wang H, Nakashima N, Basbaum AI.
    J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
    [Abstract] [Full Text] [Related]

  • 27. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
    Vanderah TW, Bernstein RN, Yamamura HI, Hruby VJ, Porreca F.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
    [Abstract] [Full Text] [Related]

  • 28. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW, Holtzman SG.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE, Pelton JT, Lemcke PK, Porreca F, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of urinary bladder contractions by a spinal action of morphine and other opioids.
    Dray A, Metsch R.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):254-60. PubMed ID: 6092610
    [Abstract] [Full Text] [Related]

  • 32. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
    Horan PJ, Mattia A, Bilsky EJ, Weber S, Davis TP, Yamamura HI, Malatynska E, Appleyard SM, Slaninova J, Misicka A.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1446-54. PubMed ID: 8389867
    [Abstract] [Full Text] [Related]

  • 33. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
    Roerig SC, Hoffman RG, Takemori AE, Wilcox GL, Fujimoto JM.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1091-9. PubMed ID: 1646321
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE, Gout R, Meunier JC, Cros J.
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
    Thor KB, Hisamitsu T, Roppolo JR, Tuttle P, Nagel J, deGroat WC.
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1018-25. PubMed ID: 2539452
    [Abstract] [Full Text] [Related]

  • 39. Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.
    Qi JN, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1990 Aug; 254(2):683-9. PubMed ID: 2166801
    [Abstract] [Full Text] [Related]

  • 40. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF, Narita M, Mizoguchi H, Kawai K, Mizusuna A, Kamei J, Suzuki T, Nagase H.
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.